Error: Could not add to watchlist. X

Durata Therapeutics Inc

+ Watchlist
DRTX:US
Acquired
DRTX:US was acquired by AGN:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.60
Market Cap (USD)
-
Shares Outstanding (m)
26.793
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Durata Therapeutics, Inc. develops and markets pharmaceutical products. The Company offers medicines for patients suffering from diseases principally in the central nervous system, gastroenterology, women's health, urology, cardiovascular, respiratory, and anti-infective therapeutic categories. Durata Therapeutics operates in the United States
ADDRESS
500 West Monroe Street
Chicago, IL 60661
United States
PHONE
1-312-219-7000
  • Corey N Fishman
    CFO/COO
  • Michael W Dunne
    Chief Medical Officer
Show More